123 related articles for article (PubMed ID: 8957552)
21. Detection of proliferating cell nuclear antigen in paraffin-embedded specimens is dependent on preembedding tissue handling and fixation.
Burford-Mason AP; MacKay AJ; Cummins M; Dardick I
Arch Pathol Lab Med; 1994 Oct; 118(10):1007-13. PubMed ID: 7524464
[TBL] [Abstract][Full Text] [Related]
22. Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinomas.
Tsai ST; Jin YT
J Oral Pathol Med; 1995 Aug; 24(7):313-5. PubMed ID: 7473268
[TBL] [Abstract][Full Text] [Related]
23. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
Paiva C; Oshima CT; Lanzoni VP; Forones NM
Hepatogastroenterology; 2002; 49(46):1058-61. PubMed ID: 12143201
[TBL] [Abstract][Full Text] [Related]
24. The identification of proliferating cell nuclear antigen (PCNA) on rat tissue cryosections and its application to double immunostaining with other markers.
Ezaki T; Yao L; Matsuno K
Arch Histol Cytol; 1995 Mar; 58(1):103-15. PubMed ID: 7542012
[TBL] [Abstract][Full Text] [Related]
25. The prognostic significance of proliferating cell nuclear antigen in clinical gastric cancer.
Mori M; Kakeji Y; Adachi Y; Moriguchi S; Maehara Y; Sugimachi K; Jessup JM; Chen LB; Steele GD
Surgery; 1993 Jun; 113(6):683-90. PubMed ID: 8099452
[TBL] [Abstract][Full Text] [Related]
26. [Contribution of proliferating cell nuclear antigen to prognostic evaluation of carcinomas of the maxillary sinus].
Mikuni H; Fukuda S; Furuta Y; Takasu T; Nagahashi T; Inuyama Y
Nihon Jibiinkoka Gakkai Kaiho; 1992 Dec; 95(12):1944-9. PubMed ID: 1362772
[TBL] [Abstract][Full Text] [Related]
27. Proliferating cell nuclear antigen distribution in verrucous carcinoma of the skin.
Noel JC; Heenen M; Peny MO; Fayt I; Peny J; De Dobbeleer G; Haot J; Galand P
Br J Dermatol; 1995 Dec; 133(6):868-73. PubMed ID: 8547037
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of proliferating cell nuclear antigen (PCNA) in squamous cell carcinoma of the esophagus.
Kinugasa S; Tachibana M; Hishikawa Y; Abe S; Yoshimura H; Monden N; Dhar DK; Nagasue N
Jpn J Clin Oncol; 1996 Dec; 26(6):405-10. PubMed ID: 9001344
[TBL] [Abstract][Full Text] [Related]
29. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
[TBL] [Abstract][Full Text] [Related]
30. [Expression of proliferating cell nuclear antigen (PCNA) in squamous cell carcinoma of the oral cavity].
Qiao B; Wu Q; Wu D
Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 Jan; 30(1):21-2, 63-4. PubMed ID: 7789227
[TBL] [Abstract][Full Text] [Related]
31. The proliferating cell nuclear antigen index in breast carcinomas does not correlate with mitotic index and estrogen receptor immunoreactivity.
Schmitt FC; Pereira EM; Andrade LM; Torresan M; de Lucca L
Pathol Res Pract; 1994 Sep; 190(8):786-91. PubMed ID: 7831155
[TBL] [Abstract][Full Text] [Related]
32. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.
Kamel OW; LeBrun DP; Davis RE; Berry GJ; Warnke RA
Am J Pathol; 1991 Jun; 138(6):1471-7. PubMed ID: 1675840
[TBL] [Abstract][Full Text] [Related]
33. [The study of proliferation of cells at the invasive tumor front of squamous cell carcinoma of tongue].
Wang XH; Wang SZ; Chen XM; Li Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2004 Jan; 39(1):49-52. PubMed ID: 14989875
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of proliferating cell nuclear antigen (PCNA) immunostaining in neuroblastoma.
Kawasaki H; Mukai K; Yajima S; Tanaka R; Takayama J; Takasaki Y; Ohira M
Med Pediatr Oncol; 1995 May; 24(5):300-4. PubMed ID: 7700181
[TBL] [Abstract][Full Text] [Related]
35. Comparison of immunostainings for proliferating cell nuclear antigen and Ki-67 in human extraocular lesions.
Kodama T; Kawamoto K; Kono T; Shibuya Y; Setogawa T
Graefes Arch Clin Exp Ophthalmol; 1997 Dec; 235(12):767-72. PubMed ID: 9439969
[TBL] [Abstract][Full Text] [Related]
36. Proliferating cell nuclear antigen counts as markers of cell proliferation in head and neck cancer.
Lörz M; Meyer-Breiting E; Bettinger R
Eur Arch Otorhinolaryngol; 1994; 251(2):91-4. PubMed ID: 7517683
[TBL] [Abstract][Full Text] [Related]
37. Influence of formalin fixation time and tissue processing method on immunoreactivity of monoclonal antibody PC10 for proliferating cell nuclear antigen.
Tahan SR; Wei Y; Ling P; Bistrian BR
Mod Pathol; 1995 Feb; 8(2):177-82. PubMed ID: 7777480
[TBL] [Abstract][Full Text] [Related]
38. [A study on tongue cancer cell labeling using bromodeoxyuridine (BrdU) incorporation in vitro].
Li X; Zhao Q; He R; Zhou X; Chen W
Hua Xi Kou Qiang Yi Xue Za Zhi; 2001 Oct; 19(5):278-80. PubMed ID: 12539478
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings.
Nishioka H; Hiasa Y; Hayashi I; Kitahori Y; Konishi N; Sugimura M
Oncology; 1993; 50(6):426-9. PubMed ID: 7901826
[TBL] [Abstract][Full Text] [Related]
40. Growth rate of intracranial meningioma: tumor doubling time and proliferating cell nuclear antigen staining index.
Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
Neurol Med Chir (Tokyo); 1995 May; 35(5):289-93. PubMed ID: 7623949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
